Shockingly, there are around 55,200 new breast cancer cases in the UK every year. As such, breast cancer is the most common invasive cancer in women and a leading cause of cancer death. In this exclusive interview, we speak with Richard Bahu, Chair of Trustees at the UK research charity Against Breast Cancer to hear about their vital work.

How did Against Breast Cancer come to fruition?

The total focus of Against Breast Cancer (ABC) is to stop secondary breast cancer from claiming lives. ABC was founded by Dr Anthony Leathem and his wife Patricia. At the time, Anthony was a pathologist at the Middlesex Hospital (later University College London) and his wife Patricia was a breast cancer theatre nurse at Oxford’s Churchill Hospital. They were deeply upset by the number of post-mortems he carried out each day on young women with breast cancer. They had to act by personally fundraising to support his research into breast cancer survival. This included Patricia planting their entire allotment with sweet peas to sell, and Anthony in his white coat outside Oxford Street tube station with a collection tin! Anthony’s research paper describing a difference between aggressive and non-aggressive breast cancer cells was the springboard for setting up ABC in 1993.

How does Against Breast Cancer support research? What types of research do you fund?

Our research strategy is set out in our Roadmap with three key areas: prevention, detection and new therapies. Prevention includes understanding how diet and lifestyle factors affect the risk of cancer recurrence. Detection aims to design better tools for the earlier detection of secondary cancer through biomarker discovery. New therapies aim to exploit the body’s immune system to create more effective treatments.

Our research strategy has created a significant critical mass of world-class researchers at Southampton University. We complement this with seed funding of researchers who have an exciting research idea but insufficient background research to apply for major funding. Often, these seed-funded projects enable them to successfully apply for major follow-on programmes. We are also committed to encouraging and developing young scientists in breast cancer research through a major fellowship programme at Oriel College, Oxford University.

How is the general public involved in your work?

We wouldn’t be where we are today without the involvement and support of the public. We have amazing supporters who help raise funds for our research projects. There are many ways people get involved, from taking part in local and national events, corporate giving, donating bras and clothes, volunteering their time and skills, and providing touching case studies. We are also grateful to those who leave a legacy in their wills. Some major companies and organisations choose ABC as their charity of the year and we work with them to give their staff a positive experience of our charity work. We also have research advocates who are people with experience with breast cancer and who provide valuable input into the types of projects that we fund.

One amazing and extremely moving example is that of Danielle. She was the focal point for a fundraising campaign in which a lock of her hair taken before her treatment was turned into diamond – the world’s most precious stone. At the end of the campaign, the diamond was incorporated into a necklace by a leading designer and donated to her young daughter.

We are, of course, in the midst of the COVID-19 pandemic. What specific difficulties has this brought to the work of Against Breast Cancer?

Clearly, this has had a dramatic effect not just on our fundraising but also on our staff and supporters. Being a smaller charity, we can react quickly to these challenges. Our team has risen to the challenge by being creative in moving activities online and into a virtual world. We have retained all our staff whilst other charities have sadly let many people go. This is a reflection of the lean management of the charity by an outstanding management team. We have also benefited from prudent management of our funds which has enabled us to cope robustly with the financial pressures.

There has been an impact on our research and with our full support, some of our researchers have joined the effort to combat the virus. However, we have been very pleased with how our researchers have sought to move their projects forward wherever possible. Again, we have continued to support all our funded projects and do not envisage cutting back any of them.

What would you say are Against Breast Cancer’s biggest achievements to date?

Reaching our 25th anniversary in 2018 was a big milestone for the charity. We are particularly proud of achieving our Biobank which is a collection of samples and lifestyle data collected from over 3,000 women over a period of 5 years post-cancer diagnosis. This is such a valuable research resource and one of the largest of its kind in the UK. To date, our research funding has now exceeded £7m and we have laboratories located at one of the world’s leading centres researching secondary breast cancer. ABC’s committed funding up to 2028 sees a portfolio of £4.5m with further funding envisaged for seed grants.

Looking now to the future, what are the main challenges and goals for Against Breast Cancer over the next 5–10 years?

ABC is now on a clear path to have a major impact on secondary breast cancer deaths over the next 5–10 years. The biggest challenge is managing the expectations of our supporters as they obviously want quick results whereas the complexity of the research requires a steady and sustained long-term effort to which we are committed. This means we have to provide clear and truthful communication about our research as often people see articles in the press and on social media which talk about breakthroughs but which often are still some way from being implemented in clinical practice.

W: https://www.againstbreastcancer.org.uk/

Twitter: @againstbc

Reference
https://doi.org/10.33548/SCIENTIA642

Want to republish our articles?

 

We encourage all formats of sharing and republishing of our articles. Whether you want to host on your website, publication or blog, we welcome this. Find out more

Creative Commons Licence
(CC BY 4.0)

This work is licensed under a Creative Commons Attribution 4.0 International License. Creative Commons License

What does this mean?

Share: You can copy and redistribute the material in any medium or format

Adapt: You can change, and build upon the material for any purpose, even commercially.

Credit: You must give appropriate credit, provide a link to the license, and indicate if changes were made.

Subscribe now!


More articles you may like

John Sauter – DSOARS: Swarming Drones for Real-world Missions

John Sauter – DSOARS: Swarming Drones for Real-world Missions

The idea of unmanned drones flying together in expansive swarms may at first sound chaotic and unpredictable – yet with the right approach, these machines can enable their users to carry out coordinated and highly advanced missions. Through their research, John Sauter and colleagues at SoarTech have developed DSOARS – a transformative software that enables drones to mimic the behaviours of swarming animals found in nature. Their architecture now paves the way for real-world applications – from tracking forest fires and storms to aiding rescue missions.

Dr Hiroaki Nishiyama – A New Solution for Direct Laser Writing

Dr Hiroaki Nishiyama – A New Solution for Direct Laser Writing

Direct Laser Writing is a remarkably useful way to deposit intricately patterned materials onto surfaces. So far, however, the range of materials that can be used in the technique has been severely restricted. Now, Dr Hiroaki Nishiyama and his team at Yamagata University in Japan introduce an entirely new approach based on the unique properties of nanoparticles when suspended in a silver-based solution. When illuminated with ultra-short laser pulses, the setup can create highly stable patterns with sophisticated nanoscale structures – substantially broadening the range of materials available for use in the technique.

Dr Lara Hwa – The Links Between Stress, Signalling and Excessive Alcohol Consumption

Dr Lara Hwa – The Links Between Stress, Signalling and Excessive Alcohol Consumption

While alcohol is often consumed to help us relieve stress and relax, excessive consumption can negatively impact the way that our brains process and cope with stress, leading to further difficulties. Dr Lara Hwa from the Department of Psychology and Neuroscience at Baylor University is investigating the link between external stressors and stress signalling in the brain to understand how these processes govern excessive drinking.

The Wasting and Stunting Technical Interest Group: Generating Evidence to Challenge the Divide in Nutrition

The Wasting and Stunting Technical Interest Group: Generating Evidence to Challenge the Divide in Nutrition

Despite improvements in children’s nutrition over the past few decades, undernutrition remains a huge threat to the health and life of infants and young children worldwide. Health and nutrition actors have usually approached the problems of children being wasted, (thinner than they should be) and children who are stunted (shorter than they should be) as different outcomes of undernutrition with different causes and different interventions. Facilitated by the Emergency Nutrition Network (ENN), since 2014 the Wasting and Stunting Technical Interest Group (WaSt TIG) has challenged this view, and has begun to work to provide evidence for a unified approach to tackling these two outcomes of undernutrition.